Document Control Specialist III jobs in United States
cer-icon
Apply on Employer Site
company-logo

Vaxcyte · 1 day ago

Document Control Specialist III

Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from bacterial diseases. They are looking for a Document Control Specialist who will be responsible for processing GxP documentation as part of the Quality Management System, including maintaining and managing document workflows and engaging with key clients to address expectations and conflicts.

BiopharmaBiotechnologyHealth Care
check
Comp. & Benefits

Responsibilities

Maintain Quality System documentation in Veeva (electronic document control system) and other electronic systems where required
Format documents to comply with Vaxcyte templates
Independently perform the QA document control function, managing document workflows in Veeva, tracking, processing, routing, distributing, and archiving documents/records with overall responsibility for document control
Engage key clients to understand expectations and problem areas and has the ability to address and resolve conflicts
Participate in developing and editing of new SOPs and work instructions
Ability to identify risks to program/process and propose solutions
Work closely with functional areas for daily management of routing, revisions, approval, and filing of documents within defined timelines
Organize and ensure accurate and reliable filing systems for all electronic

Qualification

GxP documentationVeeva VaultRegulatory complianceBiopharmaceutical experienceMicrosoft Office SuiteInterpersonal skillsOrganizational skillsAttention to detailCommunication skills

Required

Bachelor's BA/BS degree or equivalent experience and minimum of 5 years of biopharmaceutical industry experience. Other combinations of education and/or experience may be considered
Experience working with documents and records in a GxP environment relating to manufacturing and testing activities
Familiar with Veeva Vault in a Document Control capacity
Understanding of current regulatory expectations including 21CFR Part 11 requirements
Strong professional interpersonal and communications skills, both verbal and written, to provide clear direction for the business, vendors, and internal stakeholders
Strong attention to detail, organizational skills, ability to work in a faced paced environment
Ability to meet deadlines and multi-task efficiently
Proficient with Microsoft Office Suite, Word, Excel, PowerPoint

Benefits

Comprehensive benefits
An equity component

Company

Vaxcyte

twittertwitter
company-logo
Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.

Funding

Current Stage
Public Company
Total Funding
$3.85B
Key Investors
CARB-XTPG GrowthAbingworth
2024-09-04Post Ipo Equity· $1.5B
2024-01-30Post Ipo Equity· $862.5M
2023-04-19Post Ipo Equity· $500M

Leadership Team

leader-logo
Andrew Guggenhime
President & Chief Financial Officer
linkedin
leader-logo
Jeff Fairman
Founder and Vice President, Research
linkedin
Company data provided by crunchbase